Stanford University
Showing 891-900 of 1,894 Results
-
Hyeonji Kim
Visiting Instructor/Lecturer, Ophthalmology
BioDr. Kim is a translational bioprinting researcher specializing in tissue engineering and ocular regenerative medicine. She holds a Ph.D. in Mechanical Engineering. Her research focuses on developing innovative therapeutic platforms for ocular diseases using 3D bioprinting, biomanufacturing, and regenerative medicine.
She has developed 3D-bioprinted corneal stromal constructs that replicate native collagen alignment and achieve transparency, successfully restoring visual function in preclinical beagle models and subsequent veterinary clinical applications. She also advanced a simplified in situ corneal therapy that has completed veterinary clinical trials and is now licensed for anticipated human trials. Currently, she is developing ocular therapeutic implants using advanced 3D printing approaches.
Dr. Kim has collaborated with regulatory authorities and preclinical evaluation agencies to define guidelines for 3D-printed combination medical devices and to conduct safety testing of bioprinted corneas. Her work has been internationally recognized, contributing to her university's ranking as 12th in Reuters’ 2019 “Top 100 Most Innovative Universities,” and spans drug delivery, diagnostic and therapeutic devices, personalized medicine, and translational ophthalmology. Her long-term vision is to engineer personalized therapeutic implants and biofabrication technologies that bridge fundamental science and clinical translation, initially focusing on restoring vision and ultimately expanding to regenerative therapies for multiple organ systems. -
Hyunjin Kim
Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioHyunjin is a Licensing Manager at Stanford Office of Technology Licensing. Hyunjin holds a PhD in Biochemistry from the University of Illinois at Chicago. With a strong foundation in life sciences, Hyunjin joined Aspire Capital as a biotech analyst intern where she gained valuable experience in analyzing and assessing biotech companies with clinical stage assets. After the internship, Hyunjin joined the Office of Technology Management at University of Illinois at Chicago where she managed various intellectual properties. At Stanford, Hyunjin is responsible for managing life science portfolios.
